ED attaches Rs 2.58 crore property of HP Assistant Drug Controller

Shimla:  The Enforcement Directorate has provisionally attached two immovable properties worth Rs 2.58 crore as part of a money laundering probe against Assistant Drug Controller in Himachal Pradesh, Nishant Sareen, and his associate Komal Khanna, the agency said in a statement on Wednesday.

The assets, which were attached on December 2, include a residential building in Shimla and an apartment in Sector 20 of Haryana’s Panchkula.

The ED has been carrying out the investigation based on an FIR registered by the Himachal Pradesh State Vigilance and Anti-Corruption Bureau under Section 11 of the Prevention of Corruption Act, 1988.

The FIR accused Sareen of bribery, forgery and corruption when he was posted as Assistant Drug Controller at Baddi in Solan district.

Sareen was subsequently arrested, and a chargesheet was filed in 2021 against him and Khanna.

In 2022, Haryana Police registered another FIR against Sareen, Khanna and their other associates for alleged extortion, intimidation and forgery of the partnership deed of Zhenia Pharmaceuticals located in Panchkula.

Investigation revealed that Sareen’s official position was misused to allegedly raise Khanna’s share in the firm from 50 per cent to 95 per cent.

On September 23, 2025, a third FIR was registered against Sareen, accusing him of accumulating disproportionate assets worth Rs 1.66 crore while he was posted as Drug Inspector and Assistant Drug Controller in Himachal Pradesh.

The ED stated that Sareen, while being posted in various locations including Nahan, Baddi and Solan, had misused his position to collect illegal compensation from pharmaceutical manufacturers and distributors.

The probe also revealed that several pharmaceutical companies were coerced into conducting business at heavy losses with Zhenia Pharmaceuticals and Nia Pharma, both allegedly controlled and managed by Khanna.

The proceeds of crime were allegedly channelled into acquisition of personal assets, bank deposits, and properties held in the names of Khanna and Sareen’s family members.

 

Related Posts

Unapproved drops for dry eyes pose risks: Govt

NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Unapproved drops for dry eyes pose risks: Govt

Unapproved drops for dry eyes pose risks: Govt

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward

Govt highlights multi-layer framework to curb misleading advertisements

Govt highlights multi-layer framework to curb misleading advertisements

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Major breakhthrough: Sonbhadra cops nab codeine syrup racket handler in Bengal

Study finds rising resistance to a last-resort antibiotic in Africa

Study finds rising resistance to a last-resort antibiotic in Africa